Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

September 18, 2026

Study Completion Date

September 28, 2026

Conditions

HPV Infection

Interventions

BIOLOGICAL

9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use

By the percutaneous route with the multiple puncture device - 9vHPV Vaccine 1.0 mL plus BCG Organism 50 MG Mix

Trial Locations (1)

Medicine Invention Design, Inc., Rockville

All Listed Sponsors

collaborator

UnitedHealthcare

OTHER

lead

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

INDUSTRY

NCT06959563 - Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV | Biotech Hunter | Biotech Hunter